Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0009402 (
colorectal cancer
)
53,228
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hereditary
colorectal cancer
syndromes are classified according to the presence of unusually large number of adenomatous or hamartomatous polyps, or their absence. The latter category includes hereditary non-polyposis
colorectal cancer
(Lynch syndrome) and its variants Muir-Torre and Turcot's syndromes. Adenomatous polyposis syndromes include familial adenomatous polyposis (FAP) and its variants, and the recently identified MYH- (
mutY homolog
)-associated polyposis. Hamartomatous polyposis syndromes include juvenile polyposis, Peutz-Jeghers syndrome, and Cowden syndrome, which is now included within the broader category 'PTEN (phosphatase and tensin homolog) hamartoma tumour syndrome'. Other syndromes such as the 'hereditary breast and colon cancer' and 'familial
colorectal cancer
' are not yet fully characterized. This review addresses the molecular basis of these syndromes with particular reference to the recent advances in this rapidly progressive field and the applications of such knowledge in diagnosis and management.
...
PMID:Molecular basis and diagnostics of hereditary colorectal cancers. 1547 12
DNA repair is a key process in the maintenance of genome integrity. Here, we present a large, systematically collected population-based association study (2,239 cases; 1,845 controls) that explores the contribution to
colorectal cancer
incidence of inherited defects in base-excision repair (BER) genes. We show that biallelic
MUTYH
defects impart a 93-fold (95% CI 42-213) excess risk of
colorectal cancer
, which accounts for 0.8% of cases aged <55 years and 0.54% of the entire cohort. Penetrance for homozygous carriers was almost complete by age 60 years. Significantly more biallelic carriers had coexisting adenomatous polyps. However, notably, 36% of biallelic carriers had no polyps. Three patients with heterozygous
MUTYH
defects carried monoallelic mutations in other BER genes (OGG1 and MTH1). Recessive inheritance accounted for the elevated risk for those aged <55 years. However, there was also a 1.68-fold (95% CI 1.07-2.95) excess risk for heterozygous carriers aged >55 years, with a population attributable risk in this age group of 0.93% (95% CI 0%-2.0%). These data provide the strongest evidence to date for a causative role of BER defects in
colorectal cancer
etiology and show, to our knowledge for the first time, that heterozygous
MUTYH
mutations predispose to
colorectal cancer
later in life. These findings have clinical relevance for BER gene testing for patients with
colorectal cancer
and for genetic counseling of their relatives.
...
PMID:Germline susceptibility to colorectal cancer due to base-excision repair gene defects. 1696 Aug 17
Inherited biallelic mutations in the human
MUTYH
gene are responsible for the recessive syndrome--adenomatous colorectal polyposis (
MUTYH
associated polyposis, MAP)--which significantly increases the risk of
colorectal cancer
(
CRC
). Defective
MUTYH
activity causes G:C to T:A transversions in tumour APC and other genes thereby altering genomic integrity. We report that of the four established cell lines, derived from patients with the MAP phenotype and containing biallelic
MUTYH
mutations, three contain altered expressions of
MUTYH
protein (
MUTYH
Y165C(-/-),
MUTYH
1103delC/G382D and
MUTYH
Y165C/G382D but not
MUTYH
G382D(-/-)), but that all four cell lines have wild type levels of
MUTYH
mRNA. Mutant
MUTYH
proteins in these four cell lines possess significantly lowered binding and cleavage activities with heteroduplex oligonucleotides containing A.8-oxoG and 8-oxoA.G mispairs. Transfection of mitochondrial or nuclear
MUTYH
cDNAs partially correct altered
MUTYH
expression and activity in these defective cell lines. Finally, we surprisingly find that defective
MUTYH
may not alter cell survival after hydrogen peroxide and menadione treatments. The Y165C and 1103delC mutations significantly reduce
MUTYH
protein stability and thus repair activity, whereas the G382D mutation produces dysfunctional protein only suggesting different functional molecular mechanisms by which the MAP phenotype may contribute to the development of
CRC
.
...
PMID:Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair. 1598 19
Biallelic germline mutations of
MUTYH
-a gene encoding a base excision repair protein-are associated with an increased susceptibility of
colorectal cancer
. Whether monoallelic
MUTYH
mutations also increase cancer risk is not yet clear, although there is some evidence suggesting a slight increase of risk. As the
MUTYH
protein interacts with the mismatch repair (MMR) system, we hypothesised that the combination of a monoallelic
MUTYH
mutation with an MMR gene mutation increases cancer risk. We therefore investigated the prevalence of monoallelic
MUTYH
mutations in carriers of a germline MMR mutation: 40 carriers of a truncating mutation (group I) and 36 of a missense mutation (group II). These patients had been diagnosed with either colorectal or endometrial cancer. We compared their
MUTYH
mutation frequencies with those observed in a group of 134 Dutch colorectal and endometrial cancer patients without an MMR gene mutation (0.7%) and those reported for Caucasian controls (1.5%). In group I one monoallelic
MUTYH
mutation was found (2.5%). In group II five monoallelic germline
MUTYH
mutations were found (14%), four of them in MSH6 missense mutation carriers (20%). Of all patients with an MMR gene mutation, only those with a missense mutation showed a significantly higher frequency of (monoallelic)
MUTYH
mutations than the Dutch cancer patients without MMR gene mutations (P = 0.002) and the published controls (P = 0.001). These results warrant further study to test the hypothesis of mutations in MMR genes (in particular MSH6) and
MUTYH
acting together to increase cancer risk.
...
PMID:MUTYH and the mismatch repair system: partners in crime? 1640 24
To determine the frequency, mutation spectrum and phenotype of the recently described autosomal recessive
MUTYH
-associated polyposis (MAP), we performed a systematic search for
MUTYH
(
MYH
) mutations by sequencing the complete coding region of the gene in 329 unselected APC mutation-negative index patients with the clinical diagnosis of familial adenomatous polyposis (FAP) or attenuated FAP (AFAP). Biallelic germline mutations in
MUTYH
were identified in 55 of the 329 unselected patients (17%) and in another 9 selected index cases. About one-fifth (20%) of the 64 unrelated MAP patients harboured none of the 2 hot-spot missense mutations Y165C and/or G382D. Including 7 affected relatives, almost all MAP patients presented with either an attenuated (80%) or with an atypical phenotype (18%). Fifty percentage of the MAP patients had
colorectal cancer
at diagnosis. Duodenal polyposis was found in 18%, thyroid and stomach cancer in 1 case, other extraintestinal manifestations associated with FAP were not observed. In 8 families, vertical segregation was suspected; in 2 of these families, biallelic mutations were identified in 2 generations. Monoallelic changes with predicted functional relevance were found in 0.9% of the 329 patients, which is in accordance with the carrier frequency in the general population. In conclusion, biallelic
MUTYH
mutations are the underlying genetic basis in a substantial fraction of patients with adenomatous polyposis. The phenotype of MAP is best characterised as attenuated or atypical, respectively. Colorectal surveillance starting at about 18 years of age is recommended for biallelic mutation carriers and siblings of MAP patients, who refuse predictive testing.
...
PMID:MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. 1655 84
Mutations in the
MUTYH
gene have been reported to be associated with increased risk of developing
colorectal cancer
. In this study, we confirmed this association using original data on 928
colorectal cancer
cases and 845 healthy controls from Scotland. We then conducted a meta-analysis from published data on the association between mutations at
MUTYH
and
colorectal cancer
risk. We show for the first time a small but significant mono-allelic effect with a genotype relative risk (GRR) of 1.27 (95% confidence interval (CI): 1.01-1.61), and confirm and give a more precise estimate of the strong bi-allelic effect with an estimated GRR of 117 (95% CI: 74-184). This study underscores the need for large sample sizes in order to identify small gene effects when the disease allele frequency is low.
...
PMID:Association of MUTYH and colorectal cancer. 1680 17
Familial adenomatous polyposis has been linked to germline mutations in the APC tumor suppressor gene. However, a number of patients with familial adenomatous polyposis (with either classical or attenuated phenotype) have no APC mutation. Recently, germline mutations in the Wnt pathway component gene AXIN2 have been associated with tooth agenesis-
colorectal cancer
syndrome. Moreover, biallelic mutations in the base excision repair gene
MUTYH
have been associated with polyposis and early-onset
colorectal cancer
. The aim of this study was to further assess the contribution of AXIN2 and
MUTYH
to hereditary
colorectal cancer
susceptibility. AXIN2 and
MUTYH
genes were screened for germline mutations by PCR and direct sequencing in 39 unrelated patients with multiple adenomas or
colorectal cancer
without evidence of APC mutation nor mismatch repair defect. Two novel AXIN2 variants were detected in one patient with multiple adenomas, but no clearly pathogenic mutation. In contrast, nine different
MUTYH
mutations were detected in eight patients, including four novel mutations. Biallelic
MUTYH
mutations were only found in patients with multiple adenomatous polyposis (7 out of 22 (32%)). Interestingly, five
MUTYH
mutation carriers had a family history consistent with dominant inheritance. Moreover, one patient with biallelic
MUTYH
mutations presented with multiple adenomas and severe tooth agenesis. Therefore, germline mutations are rare in AXIN2 but frequent in
MUTYH
in patients with multiple adenomas. Our data suggest that genetic testing of
MUTYH
may be of interest in patients with pedigrees apparently compatible with autosomal recessive as well as dominant inheritance.
...
PMID:Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. 1694 1
Bi-allelic germline mutations in the
MUTYH
gene give rise to multiple adenomas and an increased incidence of
colorectal cancer
. In addition, duodenal adenomas and other extra-colonic manifestations have been described in
MUTYH
-associated polyposis (MAP) patients. We describe two patients with bi-allelic
MUTYH
gene mutations with duodenal carcinoma. The tumour in Patient A was detected during evaluation of non-specific abdominal complaints. Patient B was already diagnosed with tens of adenomas and a colon carcinoma, when a duodenal neoplasm was detected. The identification of somatic G>T mutations in codon 12 of the K-RAS2 gene provides evidence that the duodenal lesions were induced by
MUTYH
deficiency. Studies in larger series of MAP patients are needed to investigate the risk of upper-gastro-intestinal malignancies and to determine further guidelines for endoscopical surveillance.
...
PMID:Duodenal carcinoma in MUTYH-associated polyposis. 1694 22
The presence of multiple adenomatous polyps in the large bowel confers a high lifetime risk of
colorectal cancer
. Although many cases of classical familial adenomatous polyposis (> 100 polyps) can be accounted for by mutations in the adenomatous polyposis coli (APC) gene, a large group of patients remains with multiple (5-100) adenomas and in whom there is no detectable APC mutation. Recently two new genetic variants have been found to be associated with multiple colorectal adenomas and cancer, MYH/
MUTYH
on chromosome 1p and the HMPS/CRAC1 locus on chromosome 15q13-q14. New information also continues to emerge regarding the less common hamartomatous polyposis conditions, Peutz-Jeghers syndrome and Juvenile Polyposis syndrome. In approximately half to two thirds of these families, germline genetic variants can now be uncovered. In this review we draw together some of the most recent information pertinent to the molecular pathogenesis of colorectal polyposis.
...
PMID:The genetics of FAP and FAP-like syndromes. 1699 67
In the inherited syndromes,
MUTYH
-associated polyposis (MAP) and hereditary nonpolyposis
colorectal cancer
(HNPCC), somatic mutations occur due to loss of the caretaker function that base-repair (BER) and mismatch repair (MMR) genes have, respectively. Recently, we identified a large branch from a MSH6 HNPCC family in which 19 family members are heterozygous or compound heterozygous for
MUTYH
germ line mutations. MSH6/
MUTYH
heterozygote mutation carriers display a predominant HNPCC molecular tumour phenotype, with microsatellite instability and underrepresentation of G>T transversions. A single unique patient is carrier of the MSH6 germline mutation and is compound heterozygote for
MUTYH
. Unexpectedly, this patient has an extremely mild clinical phenotype with sofar only few adenomas at age 56. Four out of five adenomas show characteristic G>T transversions in APC and/or KRAS2, as seen in
MUTYH
associated polyposis. No second hit of MSH6 is apparent in any of the adenomas, due to retained MSH6 nuclear expression and a lack of microsatellite instability. Although this concerns only one case, we argue that the chance to find an additional one is extremely small and currently a mouse model with this genotype combination is not available. Moreover, the patients brother who is also compound heterozygous for
MUTYH
but lacks the MSH6 germline mutation presented with a full blown polyposis coli. In conclusion, these data would support the notion that abrogation of both MSH6 DNA mismatch repair and base repair might be mutually exclusive in humans.
...
PMID:The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family. 1703 70
1
2
3
4
5
6
7
8
9
10
Next >>